Breaking News, Collaborations & Alliances

Corning, Sartorius Stedim Enter Cell Culture Product Pact

Corning, Inc. and Sartorius Stedim Biotech have entered a marketing and branding collaboration to offer a full range of cell culture products through a combined product catalogue.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Corning, Inc. and Sartorius Stedim Biotech have entered a marketing and branding collaboration to offer a full range of cell culture products through a combined product catalogue. The companies will work together on marketing and sales initiatives, as well as explore options for future R&D efforts and joint product development.

“As competitive pressures in the cell culture industry continue to evolve and increase, it is critical that we are able to offer customers a full range of cell culture lab products spanning basic research to full scale production,” said Thomas Appelt, vice president and general manager, Corning Life Sciences.

“Our collaboration with another industry leader such as Sartorius Stedim Biotech will strongly position both companies for future success. Both companies are leaders in single-use technology and can serve the global cell culture community with platforms for scalable solutions for both attached cells and cells in suspension,” said Reinhard Vogt, executive vice president of Sartorius Stedim Biotech.

Click here to find out more about Sartorius Stedim Biotech

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters